||WO||WO/2014/136105 - DEVICE, SYSTEM AND METHOD FOR SUBCUTANEOUS DRUG DELIVERY||12.09.2014||
||PCT/IL2014/050213||INSULINE MEDICAL LTD.||NAGAR, Ron|
Embodiments of the present disclosure present systems, methods and devices relate to delivering a drug subcutaneously to a patient. For example, a subcutaneous drug delivery device for use in delivering a drug subcutaneously to a patient can include a needle or cannula configured for delivery of a drug from a drug reservoir to a subcutaneous tissue of a patient.
||WO||WO/2014/136107 - A CORDED LATTICE BASED FLOATING PHOTOVOLTAIC SOLAR FIELD WITH INDEPENDENTLY FLOATING SOLAR MODULES||12.09.2014||
||PCT/IL2014/050215||SOLARIS SYNERGY (ISRAEL) LTD.||KOKOTOV, Yuri|
Provided herein is a floating photovoltaic solar device designed to reduce the effect of wind forces without the use of external control or power. The device includes a floating anchored frame with a means for connecting an internal corded lattice; a corded lattice suspended within the floating frame and forming a set of polygonal cells in which independently floating solar photovoltaic modules are positioned. Access for scheduled and unscheduled maintenance may be provided by a floating service gantry. The system is modular and several devices may be connected in a honeycomb-like structure.
||WO||WO/2014/136109 - HOT WATER DISPENSER||12.09.2014||
||PCT/IL2014/050221||ZURI NAAMAN VICTOR LTD||RAOVEN, Raoven|
A Sabbath compliant hot water dispenser, comprising a primary heating chamber for cyclically receiving a dose of unheated water, heating the received unheated water to a near to scalding temperature during the Sabbath, and discharging the heated water without any human intervention A controller is used to control automatic operation of the dispenser. The Sabbath compliant water may further include a pump for cyclically delivering the dose of unheated water to the primary heating chamber during the Sabbath.
||WO||WO/2014/136110 - FREE SPACE OPTICAL COMMUNICATION SYSTEM||12.09.2014||
||PCT/IL2014/050223||SHILAT OPTICAL SYSTEMS LTD||GUETTA, Avishay|
A method and system for optical communication between a transmitter and receiver, using a video camera to image the location of the remote transmitter. The comparatively slow frame rate of conventional detector arrays, which would limit communication rate, is overcome by reading only pixels in a region of interest around the transmission source image, and these pixels can then be read out and the communication information on them retrieved, at a frame rate much faster than that of the conventional full frame read-out. Custom wiring of the array can be used to enable implementation of this increased frame rate. Other methods of increasing communication speed using a video camera array detector include spreading the optical signal spatially along a row of pixels, and reading those pixels simultaneously in one frame, or wavelength multiplexing the optical information, and dispersing the different wavelengths onto successive pixels of the array.
||WO||WO/2014/136111 - INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES||12.09.2014||
||PCT/IL2014/050225||ADVANCED INHALATION THERAPIES (AIT) LTD.||AV-GAY, Yossef|
A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disease or disorder can be associated with a nosocomial infection or with an opportunistic infection in an immune-compromised subject. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters as described in the instant specification, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.
||WO||WO/2014/136112 - PATIENT-SPECIFIC REHABILITATIVE VIDEO GAMES||12.09.2014||
||PCT/IL2014/050226||BIOGAMING LTD.||KLEIN, David Moshe|
A method for generating a patient-specific, rehabilitative video game level, the method comprising: receiving a rehabilitative therapy plan for a patient, the rehabilitative therapy plan comprising one or more physical exercises; and automatically translating the therapy plan to a video game level configured for execution by a motion recognition gaming system.
||WO||WO/2014/136114 - TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME||12.09.2014||
||PCT/IL2014/050228||PROTALIX LTD.||SHAALTIEL, Yoseph|
A plant produced TNF alpha polypeptide inhibitor is provided. Also provided are methods of generating and using same.
||WO||WO/2014/136115 - NON-SELFABSORBING LUMINESCENT SOLAR CONCENTRATOR||12.09.2014||
||PCT/IL2014/050229||YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.||REISFELD, Renata|
A luminescent solar concentrator (LSC) is provided, which is capable of absorbing solar energy in the UV and visible regions of the spectrum, the LSC incorporating a luminescent system comprising at least two rare earth materials.
||WO||WO/2014/136113 - CHIMERIC POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME||12.09.2014||
||PCT/IL2014/050227||PROTALIX LTD.||SHAALTIEL, Yoseph|
A plant produced chimeric polypeptide is provided. The plant produced chimeric polypeptide comprising: (i) a first domain which comprises a TNF Alpha binding domain of a TNF receptor, and (ii) a second domain which comprises an Fc domain of an immunoglobulin, wherein the first domain and the second domain are N-terminally to C-terminally respectively sequentially translationally fused and wherein the chimeric polypeptide specifically binds TNF Alpha.
||WO||WO/2014/136116 - LIPID CONJUGATES IN THE TREATMENT OF BRONCHITIS||12.09.2014||
||PCT/IL2014/050230||YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.||YEDGAR, Saul|
Provided herein are methods of treating, suppressing, inhibiting, or preventing bronchitis in a subject comprising the step of administering to a subject a compound comprising a lipid or phospholipid moiety bond to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof.